SCHEMBL7299933

SCHEMBL7299933

CCCC(=O)c1cccc2c(C(=O)CCC)cc[c]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.42
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
GMNN O75496 2/20 0.42
POLB P06746 2/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 2/20 0.42
BLM P54132 2/20 0.42
PMP22 Q01453 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CMKLR1 Q99788 2/20 0.42
ALOX15 P16050 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387862 0.75 HPGD (0.40) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL29875679 0.74 ALDH1A1 (0.70) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL1716864 0.74 ALDH1A1 (0.70) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL13656741 0.72 GABRA1 (0.54) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL4104928 0.71 CYP1A2 (0.46) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL4116766 0.71 ALDH1A1 (0.45) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL5309095 0.70 CTNNB1 (0.46) HPGDALDH1A1TDP1TSHRKMT2A
SCHEMBL10975649 0.70 ALDH1A1 (0.47) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL28879929 0.69 ALDH1A1 (0.58) HPGDALDH1A1TDP1LMNATSHR
SCHEMBL29875909 0.69 ALDH1A1 (0.58) HPGDALDH1A1TDP1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1070487-C Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO CO (JP) 2001-09-05 CN disclosed
EP-0609058-B1 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO CO (JP) 1998-12-09 EP disclosed
US-5792840-A SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES SANKYO COMPANY, LIMITED (JP) 1998-08-11 US disclosed
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0437016-B1 Lipid A analogues having immunoactivating and anti-tumour activity SANKYO CO (JP) 1996-05-01 EP disclosed
US-5491167-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY, LIMITED (JP) 1996-02-13 US disclosed
CN-1029405-C Lipid A analogs having immunoactivating and anti-tumor activity SANKYO CO (JP) 1995-08-02 CN disclosed
CN-1091432-A Can suppress the active peptide of hiv protease, its preparation with and medical use SANKYO CO (JP) 1994-08-31 CN disclosed
EP-0609058-A2 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1994-08-03 EP disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed
CN-1064683-A New beta-amino-alpha-hydroxycarboxylic acids and uses thereof SANKYO CO (JP) 1992-09-23 CN disclosed
EP-0498680-A1 New beta-amino-alpha-hydroxycarboxylic acids and their use Sankyo Company Limited (JP) 1992-08-12 EP disclosed
CN-1052481-A Lipoid category-A with immunocompetence and anti-tumor activity is like thing SANKYO CO (JP) 1991-06-26 CN disclosed